Related Experiment Video
Updated: Jun 13, 2026

A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
Published on: May 4, 2021
Breathing Out the Truth: What Fractional Exhaled Nitric Oxide Really Tells Us About Pediatric Asthma
Adriana Mihai1,2, Ileana Katerina Ioniuc1,2, Alina Mariela Murgu1,2
1Grigore T. Popa University of Medicine and Pharmacy, 700115 Iași, Romania.
Insights
Fractional exhaled nitric oxide (FeNO) aids in diagnosing and managing pediatric asthma when lung function tests are difficult. This biomarker offers valuable insights for treatment and monitoring, improving precision in care.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
- Biomarker Research
Background:
- Childhood asthma diagnosis and monitoring present challenges, especially in young children.
- Objective assessment of airway inflammation is crucial but often limited by conventional methods.
- Fractional exhaled nitric oxide (FeNO) is an emerging tool for evaluating airway inflammation.
Purpose of the Study:
- To review the clinical utility of FeNO in pediatric asthma.
- To assess FeNO's role in diagnosis, treatment guidance, and disease monitoring.
- To evaluate FeNO as a complementary biomarker in childhood asthma management.
Main Methods:
- A narrative review of studies published between January 2015 and October 2025.
- Literature search conducted in PubMed using keywords related to FeNO, asthma, and pediatrics.
- Inclusion of 47 studies after applying eligibility criteria.
Main Results:
- FeNO demonstrates moderate-to-good diagnostic accuracy for childhood asthma (sensitivity 0.79, specificity 0.81).
- FeNO-guided therapy may decrease exacerbations in some pediatric patients, but effects on symptoms and steroid use are inconsistent.
- Serial FeNO measurements can inform inflammatory control, adherence, and exacerbation risk, though influenced by confounding factors.
Conclusions:
- FeNO is a valuable complementary biomarker for pediatric asthma, enhancing diagnostic and therapeutic precision.
- Optimal use of FeNO requires integration into a multimodal clinical approach, not as a standalone tool.
- Further research may clarify FeNO's role in specific asthma phenotypes and treatment strategies.
Abstract:
Asthma is the most prevalent chronic respiratory disease in childhood, and the objective assessment of airway inflammation remains a major challenge, particularly in younger children in whom conventional lung function testing is often not feasible. The aim of this narrative review is to evaluate the clinical role of fractional exhaled nitric oxide (FeNO) in pediatric asthma, focusing on its diagnostic utility, role in treatment guidance, and value in disease monitoring. A structured literature search was conducted in PubMed for studies published between January 2015 and October 2025, using predefined keywords related to FeNO, asthma, and pediatric populations. After applying the eligibility criteria, 47 studies were included in the final synthesis. Evidence from systematic reviews and clinical studies indicates that FeNO has moderate-to-good diagnostic accuracy for childhood asthma, with a pooled sensitivity of 0.79 and specificity of 0.81, and is most useful as an adjunct to clinical assessment and lung function testing. FeNO-guided therapy may reduce exacerbation rates in selected pediatric populations, although its effects on symptom control and corticosteroid use remain inconsistent. In the monitoring setting, serial FeNO measurements may provide additional information on inflammatory control, treatment adherence, and risk of future exacerbations. However, interpretation is influenced by multiple confounding factors, including atopy, allergic rhinitis, corticosteroid therapy, and asthma phenotype. In conclusion, FeNO is a valuable complementary biomarker in pediatric asthma, with particular utility in improving diagnostic and therapeutic precision. Its optimal use requires careful integration within a multimodal clinical framework rather than reliance as a standalone tool.
Related Concept Videos
Pulmonary Cycle: Exhalation
Breathing
Asthma III: Clinical Manifestations
Physical Assessment of the Respiratory Tract II: Inspection
Chest Configuration
The chest configuration can...
Physiological Control of Respiration
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
Asthma I: Introduction
